oppn parties Vaccine Production Needs To Be Increased And More Vaccines Need To Be Approved

News Snippets

  • Supreme Court says all cases of mob violence and lynchings should not be given a communal angle
  • Supreme Court tells petitioners who want elections to be held with ballot papers as they fear EVM tampering to back their claims of tampering with data
  • PM Modi says he is indebted to the Constitution which is an article of paith for his party
  • Mamata Banerjee says people do not have freedom to eat what they want under NDA then how can they have freedom to speak
  • Bengal, wary of clashes on Ramnavami, has tightened security all over the state, especially in pockets that witnessed such clashes in previous years
  • Ramdev and Balkrishna of Patanjali offered apology to the Supreme Court for misleading advertisement with folded hands. The apex court had earlier said their apology was not worth the paper it was written on
  • A whistleblower has claimed that China bribed senior UN officials to keep the lab leak angle out of reasons for spread of Covid
  • Two men from Bihar were arrested from Gujarat for firing at actor Salman Khan's home on Sunday morning. Mumbai Police said they wanted to kill the actor
  • Supreme Court order West Bengal governor to appoint VCs to six universities from the names provided by the state government in one week
  • Wow! Momo raises Rs 70cr from Z3Partners in the latest round of funding
  • IMF raises India's growth forecast from 6.5% earlier to 6.8%
  • Re plunges to a new low of 83.54 per dollar as global tensions mount
  • Stocks remain weak and negative on Tuesday: Sensex plunges 456 points to 72943 and Nifty 124 points to 22147
  • Candidates' Chess: D Gukesh draws with Ian Nepomniachtchi and with six points each, both reamin joint leaders. Pragg also drew with Vidit Gujrathi
  • IPL: Table-toppers RR beat KKR by 2 wickets
Encounter at Kanker in Bastar in Chhatisgarh: 29 Maoists, including 3 'senior commanders' gunned down by security forces
oppn parties
Vaccine Production Needs To Be Increased And More Vaccines Need To Be Approved

By Sunil Garodia
First publised on 2021-04-08 06:32:24

About the Author

Sunil Garodia Editor-in-Chief of indiacommentary.com. Current Affairs analyst and political commentator.

Is India's vaccination programme in the danger of getting derailed? Three things point to this. In the first, more than 10 states have made representations to the Centre for additional stocks saying that their stocks will not last for the next 3-4 days. Maharashtra’s case is particularly grim with reports of several centres in the state stopping vaccination due to low or no stocks. In the second, AstraZeneca has already served a legal notice on Serum Institute for reneging on supply commitments while Serum has petitioned the Centre to provide Rs. 3000 crore to ramp up production. In the third, despite three months having passed since the vaccination drive started, India is still making do with only two vaccine candidates and others have not been approved for inoculation in the country. Russia is willing to get Sputnik manufactured in India and India would do well to approve it after necessary tests. There are other candidates too which can be seriously looked at. India has manufacturing capacity and it should be used gainfully now.

The government has to take these decisions fast. It has to approve other vaccine candidates and get those vaccines manufactured in India. Import is an option but it will be costly as Serum supplies Covishield at a highly-subsidized rate of just Rs. 150 per dose to the government. At the same time, it must look into ways to ramp up production and supplies of both Covishield and Covaxin. Presently, India is administering between 25 to 35 lakh doses per day. At this rate, India needs 9 crore doses per month. At their present production capacity, both Serum Institute and Bharat Biotech are incapable of servicing the vaccine programme. Production has to be ramped up and new vaccines have to be approved if the vaccination drive is to be sustained at current levels and expanded in the near future.